← back to search
Jeffrey L. Probstfield
Seattle University
· US
Area of research
Endocrinology, Diabetes and Metabolism · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Medicine, Spironolactone, Ejection fraction, Heart failure, Cardiology, and Lixisenatide.
h-index
—
citations
5,019
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
New England Journal of Medicine
2015
cited by
2,319
position: middle
doi
Spironolactone for Heart Failure with Preserved Ejection Fraction
New England Journal of Medicine
2014
cited by
2,700
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Rafael Díaz
· Estudios Clínicos Latinoamérica
2
papers (2014–2015)
Eldrin F. Lewis
· Morehouse School of Medicine
2
papers (2014–2015)
Marc A. Pfeffer
· Harvard University
2
papers (2014–2015)
Scott D. Solomon
· Harvard University
2
papers (2014–2015)
Sanjiv J. Shah
· Akron General Medical Center
1
papers (2014–2014)
Inder S. Anand
· University of Minnesota
1
papers (2014–2014)
Brian Claggett
· Harvard University
1
papers (2014–2014)
Jerome L. Fleg
· National Institutes of Health
1
papers (2014–2014)
Sonja M. McKinlay
· University of Michigan–Ann Arbor
1
papers (2014–2014)
Hertzel C. Gerstein
· McMaster University
1
papers (2015–2015)
John J.V. McMurray
· University of Glasgow
1
papers (2015–2015)
Eileen O’Meara
· Montreal Heart Institute
1
papers (2014–2014)
Lars Køber
· Nordsjællands Hospital
1
papers (2015–2015)
John F. Heitner
· Harvard University
1
papers (2014–2014)
Xiaodan Wei
· University of Connecticut
1
papers (2015–2015)
Brian Claggett
· Harvard University
1
papers (2015–2015)
Jean‐Claude Tardif
· United States Nuclear Regulatory Commission
1
papers (2015–2015)
—
·
1
papers (2015–2015)
Susan F. Assmann
· Boston Medical Center
1
papers (2014–2014)
—
·
1
papers (2014–2014)